|
US3133858A
(en)
*
|
1954-03-24 |
1964-05-19 |
Abbott Lab |
Stable thiobarbituric acid solution
|
|
CH527207A
(de)
|
1968-05-08 |
1972-08-31 |
Ceskoslovenska Akademie Ved |
Verfahren zur Herstellung von 1-Glycosyl-5-azacytosinen
|
|
DE2105468A1
(en)
|
1970-04-23 |
1971-11-18 |
Czeskoslovenska akademie ved, Prag; VtnKarstedt, E., Dipl.-Ing. Dr., Pat-Anw., 4200 Oberhausen |
1-glycosyl-5-aza-cytosines prepn
|
|
US5157120A
(en)
|
1980-09-16 |
1992-10-20 |
Syntex (U.S.A.) Inc. |
Guanine derivatives
|
|
US4855304A
(en)
|
1985-01-10 |
1989-08-08 |
Repligen Corporation |
Dinucleoside pyrophosphates and pyrophosphate homologs as plant antivirals
|
|
JPS61176523A
(ja)
|
1985-01-30 |
1986-08-08 |
Teruhiko Beppu |
制癌剤
|
|
GB8612826D0
(en)
|
1986-05-27 |
1986-07-02 |
Boots Co Plc |
Insecticidal compositions
|
|
DE3712786A1
(de)
|
1987-04-15 |
1988-11-03 |
Merck Patent Gmbh |
Verfahren und mittel zur bestimmung von nucleinsaeuren
|
|
CS269077B1
(cs)
|
1987-10-01 |
1990-04-11 |
Piskala Alois |
Způsob přípravy 5-azacytosinů
|
|
US5736531A
(en)
|
1987-10-28 |
1998-04-07 |
Pro-Neuron, Inc. |
Compositions of chemotherapeutic agent or antiviral agent with acylated pyrimidine nucleosides
|
|
US5968914A
(en)
|
1987-10-28 |
1999-10-19 |
Pro-Neuron, Inc. |
Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides
|
|
US4904770A
(en)
|
1988-03-24 |
1990-02-27 |
Bristol-Myers Company |
Production of 2',3'-dideoxy-2',3'-didehydronucleosides
|
|
US5324831A
(en)
|
1988-04-06 |
1994-06-28 |
The United States Of America As Represented By The Secretary Of Health And Human Services |
Phosphoramidite reagent for chemical synthesis of modified DNA
|
|
PT93772A
(pt)
|
1989-04-17 |
1991-01-08 |
Searle & Co |
Processo para a preparacao de composicoes para o tratamento de neoplasias, contendo um agente anti-neoplastico, por exemplo doxorubicina e um agente protector para reduzir os efeitos secundarios, por exemplo carbetimer
|
|
ZA923640B
(en)
|
1991-05-21 |
1993-02-24 |
Iaf Biochem Int |
Processes for the diastereoselective synthesis of nucleosides
|
|
CA2111571C
(en)
|
1991-07-05 |
2005-08-23 |
Reid W. Von Borstel |
Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides
|
|
IL103311A0
(en)
|
1991-10-07 |
1993-03-15 |
Univ Johns Hopkins |
Formation of triple helix complexes of single stranded nucleic acids using nucleoside oligomers
|
|
JPH05219974A
(ja)
|
1992-02-13 |
1993-08-31 |
Mitsui Petrochem Ind Ltd |
トロパンアルカロイドの製造方法
|
|
JPH05246891A
(ja)
*
|
1992-03-09 |
1993-09-24 |
Kobayashi Seiyaku Kogyo Kk |
安定な抗膵炎用注射液
|
|
US5607691A
(en)
|
1992-06-12 |
1997-03-04 |
Affymax Technologies N.V. |
Compositions and methods for enhanced drug delivery
|
|
WO1994026761A1
(en)
|
1993-05-14 |
1994-11-24 |
Pro-Neuron, Inc. |
Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides
|
|
GB9311252D0
(en)
|
1993-06-01 |
1993-07-21 |
Hafslund Nycomed As |
Cell growth regualtors
|
|
EP0734436B1
(en)
|
1993-11-30 |
1999-04-14 |
McGILL UNIVERSITY |
Inhibition of dna methyltransferase
|
|
US6432924B1
(en)
|
1993-12-26 |
2002-08-13 |
East Carolina University |
Method of treating disorders characterized by overexpression of cytidine deaminase or deoxycytidine deaminase
|
|
US5856090A
(en)
|
1994-09-09 |
1999-01-05 |
The Scripps Research Institute |
DNA-methylase linking reaction
|
|
US20030104576A1
(en)
|
1994-10-07 |
2003-06-05 |
Jonathan W. Nyce |
Dna construct, composition, formulations & methods for making the construct & for modulating expression
|
|
JPH11505422A
(ja)
|
1995-05-19 |
1999-05-21 |
フィテラ インク． |
植物細胞培養物および植物組織培養物の処理方法
|
|
DE69637669D1
(de)
|
1995-06-06 |
2008-10-16 |
Osiris Therapeutics Inc |
Myogene differenzierung menschlicher mesenchymaler stammzellen
|
|
KR19990076695A
(ko)
|
1995-12-22 |
1999-10-15 |
리차드 알. 이킨 |
시티딘 데아미나제 혹은 데옥시시티딘 데아미나제의 과발현과연관된 질병들을 치료하기 위한 활성제_및 방법
|
|
ATE238328T1
(de)
|
1996-10-16 |
2003-05-15 |
Ribapharm Inc |
Monozyklische l-nukleoside, analoga und ihre anwendungen
|
|
US6423692B2
(en)
|
1997-04-24 |
2002-07-23 |
Dana-Farber Cancer Institute, Inc. |
Method of enhancing the effectiveness of DCK phosphorylated molecules
|
|
US6153383A
(en)
|
1997-12-09 |
2000-11-28 |
Verdine; Gregory L. |
Synthetic transcriptional modulators and uses thereof
|
|
CZ298364B6
(cs)
|
1998-02-05 |
2007-09-05 |
Smithkline Beecham Biologicals S. A. |
Deriváty antigenu asociovaných s nádory z MAGE rodiny a sekvence nukleových kyselin kodující tyto deriváty, jejich použití pro prípravu fúzních proteinu a prostredku pro vakcinaci
|
|
AU766084B2
(en)
|
1998-10-19 |
2003-10-09 |
Methylgene, Inc. |
Modulation of gene expression by combination therapy
|
|
CZ302706B6
(cs)
|
1998-12-23 |
2011-09-14 |
Pfizer Inc. |
Lidská monoklonální protilátka, farmaceutická kompozice tuto protilátku obsahující, bunecná linie produkující tuto protilátku, izolovaná molekula kódující težký nebo lehký retezec uvedené protilátky, hostitelská bunka obsahující tuto izolovanou molek
|
|
WO2000040269A2
(en)
|
1999-01-05 |
2000-07-13 |
Lee Clarence C |
Pharmaceutical compositions for treatment of diseased tissues
|
|
AU4347500A
(en)
|
1999-04-13 |
2000-11-14 |
Rutgers, The State University Of New Jersey |
Ubiquitin cross-reactive protein as a prognostic marker for tumor cell chemosensitivity
|
|
WO2000074634A2
(en)
|
1999-06-03 |
2000-12-14 |
Au Jessie L S |
Methods and compositions for modulating cell proliferation and cell death
|
|
DE19935303A1
(de)
|
1999-07-28 |
2001-02-08 |
Aventis Pharma Gmbh |
Oligonukleotide zur Inhibierung der Expression von humanem eg5
|
|
EP1212422B1
(en)
|
1999-08-24 |
2007-02-21 |
Medarex, Inc. |
Human ctla-4 antibodies and their uses
|
|
JP2001163776A
(ja)
*
|
1999-09-30 |
2001-06-19 |
Nisshin Oil Mills Ltd:The |
安定化された液剤
|
|
CA2386476A1
(en)
|
1999-10-18 |
2001-04-26 |
Emory University |
Tms1 compositions and methods of use
|
|
WO2001069262A1
(en)
|
2000-03-15 |
2001-09-20 |
University Of Massachusetts |
ERβ-MEDIATED GENE EXPRESSION
|
|
WO2002021140A1
(en)
|
2000-09-08 |
2002-03-14 |
Metabolic Engineering Laboratories Co., Ltd. |
Nucleic acid sequences and proteins involved in cellular senescence
|
|
US6919370B2
(en)
*
|
2000-11-28 |
2005-07-19 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof
|
|
WO2002053138A2
(en)
|
2001-01-02 |
2002-07-11 |
Elisabeth Shanahan-Prendergast |
Treatment for inhibiting neoplastic lesions using incensole and/or furanogermacrens
|
|
SK286630B6
(sk)
|
2001-01-22 |
2009-02-05 |
Merck & Co., Inc. |
Nukleozidové deriváty, farmaceutický prostriedok s ich obsahom a ich použitie
|
|
JP2002223753A
(ja)
|
2001-01-30 |
2002-08-13 |
Hitachi Ltd |
薬物応答解析用オリゴヌクレオチドアレイ
|
|
WO2002076486A2
(en)
|
2001-02-05 |
2002-10-03 |
Innoventus Project Ab |
Histidine-rich glycoprotein
|
|
US6613753B2
(en)
|
2001-02-21 |
2003-09-02 |
Supergen, Inc. |
Restore cancer-suppressing functions to neoplastic cells through DNA hypomethylation
|
|
WO2002069903A2
(en)
|
2001-03-06 |
2002-09-12 |
Biocryst Pharmaceuticals, Inc. |
Nucleosides, preparation thereof and use as inhibitors of rna viral polymerases
|
|
US20060194275A1
(en)
|
2001-04-13 |
2006-08-31 |
Incyte Corporation |
Transporter and ion channels
|
|
US6905669B2
(en)
|
2001-04-24 |
2005-06-14 |
Supergen, Inc. |
Compositions and methods for reestablishing gene transcription through inhibition of DNA methylation and histone deacetylase
|
|
NZ528994A
(en)
|
2001-04-26 |
2006-02-24 |
Control Delivery Sys Inc |
Sustained release drug delivery system containing codrugs
|
|
US20030148973A1
(en)
|
2001-05-23 |
2003-08-07 |
Peter Emtage |
MAGE-A1 peptides for treating or preventing cancer
|
|
US20020197639A1
(en)
|
2001-06-08 |
2002-12-26 |
Shia Michael A. |
Methods and products for analyzing nucleic acids based on methylation status
|
|
JP2002370939A
(ja)
|
2001-06-12 |
2002-12-24 |
Taisho Pharmaceut Co Ltd |
育毛剤
|
|
US20030045497A1
(en)
|
2001-07-27 |
2003-03-06 |
Geneinvent Bbl Ab |
Methylation resistant vectors
|
|
SE0102627L
(sv)
|
2001-07-27 |
2002-11-19 |
Geneinvent Bbl Ab |
Vektorer motståndskraftiga mot metylering
|
|
WO2003012085A1
(en)
|
2001-07-30 |
2003-02-13 |
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. |
Antigen presenting cells, method for their preparation and their use for cancer vaccines
|
|
EP2177223B9
(en)
|
2001-09-05 |
2012-10-31 |
Ivax International Gmbh |
Homoharringtonine alone or combined with other agents for use in treating chronic myelogenous leukemia resistant or intolerant to protein kinase inhibitors other than STI 571
|
|
US20030158598A1
(en)
|
2001-09-17 |
2003-08-21 |
Control Delivery Systems, Inc. |
System for sustained-release delivery of anti-inflammatory agents from a coated medical device
|
|
IN2014DN10834A
(https=)
|
2001-09-17 |
2015-09-04 |
Psivida Inc |
|
|
EP1429713A4
(en)
|
2001-09-24 |
2007-08-08 |
Jessie L S Au |
METHOD AND COMPOSITIONS FOR DETERMINING THE CHEMOSENSIBILIZING DOSAGE OF SURAMINE IN COMBINATION THERAPY
|
|
US7432050B2
(en)
|
2001-10-05 |
2008-10-07 |
Case Western Reserve University |
Methods and compositions for detecting colon cancers
|
|
WO2003040363A1
(en)
|
2001-11-08 |
2003-05-15 |
Japan Science And Technology Agency |
Rice transposon genes
|
|
EP1492523A2
(en)
|
2001-11-23 |
2005-01-05 |
Chugai Seiyaku Kabushiki Kaisha |
Method for identification of tumor targeting enzymes
|
|
US7771998B2
(en)
|
2001-11-29 |
2010-08-10 |
Dandrit Biotech A/S |
Pharmaceutical composition for inducing an immune response in a human or animal
|
|
US20050080027A1
(en)
|
2001-11-30 |
2005-04-14 |
Markus Horer |
Optimized production of viral vectors derived from paroviruses in packaging and production cells by hsv infection or treatment with dna methylation inhibitors
|
|
GB0201498D0
(en)
|
2002-01-23 |
2002-03-13 |
Biotech Res Ventures Pte Ltd |
Materials and methods for treating cancer
|
|
US6998391B2
(en)
|
2002-02-07 |
2006-02-14 |
Supergen.Inc. |
Method for treating diseases associated with abnormal kinase activity
|
|
US20030147813A1
(en)
|
2002-02-07 |
2003-08-07 |
John Lyons |
Method for treating chronic myelogenous leukemia
|
|
CA2478640A1
(en)
|
2002-03-13 |
2003-09-18 |
F. Hoffmann-La Roche Ag |
Method for selecting drug sensitivity-determining factors and method for predicting drug sensitivity using the selected factors
|
|
JP2003310293A
(ja)
|
2002-04-26 |
2003-11-05 |
Mitsui Chemicals Inc |
ヌクレオシド化合物の製造法
|
|
SG187991A1
(en)
|
2002-05-02 |
2013-03-28 |
Wyeth Corp |
Calicheamicin derivative-carrier conjugates
|
|
US6982253B2
(en)
|
2002-06-05 |
2006-01-03 |
Supergen, Inc. |
Liquid formulation of decitabine and use of the same
|
|
US20040053304A1
(en)
|
2002-06-05 |
2004-03-18 |
Case Western Reserve University |
Methods and compositions for detecting cancers
|
|
US20040162263A1
(en)
|
2002-10-31 |
2004-08-19 |
Supergen, Inc., A Delaware Corporation |
Pharmaceutical formulations targeting specific regions of the gastrointesinal tract
|
|
US20050037992A1
(en)
|
2003-07-22 |
2005-02-17 |
John Lyons |
Composition and method for treating neurological disorders
|
|
US20050059682A1
(en)
|
2003-09-12 |
2005-03-17 |
Supergen, Inc., A Delaware Corporation |
Compositions and methods for treatment of cancer
|
|
WO2005033278A2
(en)
|
2003-09-30 |
2005-04-14 |
Ludwig Institute For Cancer Research |
In vivo efficacy of ny-eso-1 plus iscom
|
|
US7846436B2
(en)
|
2003-11-28 |
2010-12-07 |
Chemgenes Corporation |
Oligonucleotides and related compounds
|
|
US20050266012A1
(en)
|
2004-05-26 |
2005-12-01 |
Jean-Marie Andrieu |
Compositions comprising demethylating agents as enhancers of immunotherapy for the treatment of chronic infections and neoplastic diseases and methods for treating the same
|
|
US20060014949A1
(en)
*
|
2004-07-13 |
2006-01-19 |
Supergen Inc. |
Compositions and formulations of decitabine polymorphs and methods of use thereof
|
|
US20060069060A1
(en)
|
2004-09-27 |
2006-03-30 |
Sanjeev Redkar |
Salts of decitabine
|
|
US20060063735A1
(en)
|
2004-09-17 |
2006-03-23 |
Supergen, Inc. |
Salts of 5-azacytidine
|
|
WO2006048749A1
(en)
|
2004-11-04 |
2006-05-11 |
Pfizer Products Inc. |
Ctla-4 antibody and aromatase inhibitor or combination treatment for breast cancer
|
|
US20060128654A1
(en)
|
2004-12-10 |
2006-06-15 |
Chunlin Tang |
Pharmaceutical formulation of cytidine analogs and derivatives
|
|
US20060128653A1
(en)
|
2004-12-10 |
2006-06-15 |
Chunlin Tang |
Pharmaceutical formulation of decitabine
|
|
PL1833506T3
(pl)
|
2004-12-29 |
2016-01-29 |
Mannkind Corp |
Zastosowanie kompozycji zawierających różne antygeny związane z nowotworem jako szczepionek przeciwnowotworowych
|
|
US7250416B2
(en)
|
2005-03-11 |
2007-07-31 |
Supergen, Inc. |
Azacytosine analogs and derivatives
|
|
JO2787B1
(en)
*
|
2005-04-27 |
2014-03-15 |
امجين إنك, |
Alternative amide derivatives and methods of use
|
|
DK2439273T3
(da)
|
2005-05-09 |
2019-06-03 |
Ono Pharmaceutical Co |
Humane monoklonale antistoffer til programmeret død-1(pd-1) og fremgangsmåder til behandling af cancer ved anvendelse af anti-pd-1- antistoffer alene eller i kombination med andre immunterapeutika
|
|
PT1907424E
(pt)
|
2005-07-01 |
2015-10-09 |
Squibb & Sons Llc |
Anticorpos monoclonais humanos para o ligando 1 de morte programada (pd-l1)
|
|
US7700567B2
(en)
|
2005-09-29 |
2010-04-20 |
Supergen, Inc. |
Oligonucleotide analogues incorporating 5-aza-cytosine therein
|
|
US20070117776A1
(en)
|
2005-11-04 |
2007-05-24 |
John Lyons |
Low Dose Therapy Of DNA Methylation Inhibitors
|
|
US20070105792A1
(en)
|
2005-11-04 |
2007-05-10 |
Dimartino Jorge F |
Administration Of DNA Methylation Inhibitors For Treating Epigenetic Diseases
|
|
CN101637444B
(zh)
*
|
2006-03-17 |
2012-08-15 |
山东蓝金生物工程有限公司 |
含吉西他滨的抗癌药物缓释注射剂
|
|
US20090142337A1
(en)
*
|
2006-05-08 |
2009-06-04 |
Astex Therapeutics Limited |
Pharmaceutical Combinations of Diazole Derivatives for Cancer Treatment
|
|
US8003324B2
(en)
*
|
2007-10-18 |
2011-08-23 |
U.S. Department Of Veterans Affairs |
Modulation of sodium channels by nicotinamide adenine dinucleotide
|
|
CN101570553B
(zh)
*
|
2008-05-04 |
2012-03-28 |
上海医药工业研究院 |
一种2-脱氧-d-核糖的衍生物及其制备方法和用途
|
|
CN101361718B
(zh)
*
|
2008-09-26 |
2013-08-28 |
深圳万乐药业有限公司 |
稳定的地西他滨冻干制剂的制备方法
|
|
CN101787046B
(zh)
*
|
2010-02-11 |
2012-12-26 |
福建南方制药股份有限公司 |
地西他滨的中间体化合物的制备方法
|
|
GB201006096D0
(en)
|
2010-04-13 |
2010-05-26 |
Alligator Bioscience Ab |
Novel compositions and uses thereof
|
|
MX349622B
(es)
|
2010-09-08 |
2017-08-07 |
Halozyme Inc |
Metodos para evaluar e identificar o evolucionar proteinas terapeuticas condicionalmente activas.
|
|
CN101966157B
(zh)
*
|
2010-10-14 |
2013-08-14 |
苏州特瑞药业有限公司 |
一种地西他滨缓释微球及其制备方法
|
|
NZ713461A
(en)
|
2011-04-15 |
2017-02-24 |
Compugen Ltd |
Polypeptides and polynucleotides, and uses thereof for treatment of immune related disorders and cancer
|
|
EP3431142B1
(en)
|
2011-08-30 |
2020-06-17 |
Astex Pharmaceuticals, Inc. |
Decitabine derivative formulations
|
|
US9872873B2
(en)
|
2012-02-06 |
2018-01-23 |
Fresenius Kabi Oncology Limited |
Process for preparing stable pharmaceutical compositions of compounds susceptible to hydrolysis
|
|
CA2902433A1
(en)
|
2013-03-01 |
2014-09-04 |
Astex Pharmaceuticals, Inc. |
Drug combinations
|
|
AU2016287585B2
(en)
|
2015-07-02 |
2020-12-17 |
Otsuka Pharmaceutical Co., Ltd. |
Lyophilized pharmaceutical compositions
|
|
RU2020108580A
(ru)
|
2017-08-03 |
2021-09-03 |
Оцука Фармасьютикал Ко., Лтд. |
Лекарственное соединение и способы его очистки
|